The Point for North America

Research evidence excerpt

The Point for North America

/ Non-US Research Analyst Disclosures” for the details of the

employment entity of the analysts.

The Product is made available in India by Citigroup Global Markets India Private Limited (CGM), which is regulated by the

Securities and Exchange Board of India (SEBI), as a Research Analyst (SEBI Registration No. INH000000438). CGM is also

actively involved in the business of merchant banking (SEBI Registration No. INM000010718) and stock brokerage ((SEBI

Registration No. INZ000263033) in India, and is registered with SEBI in this regard. Registration granted by SEBI, enlistment

with Bombay Stock Exchange (BSE) and certification from National Institute of Securities Markets (NISM) in no way guarantee

performance of the intermediary or provide any assurance of returns to investors. CGM’s registered office is at 1202, 12th Floor,

First International Financial Centre (FIFC), G Block, Bandra Kurla Complex, Bandra East, Mumbai – 400098 & registered Tel:

+91 22 61759999. Citi maintains robust policies, procedures,controls, and training to ensure continued compliance with all

applicable rulesand regulations. All recommendations contained herein are made by dulyqualified research analysts. CGM’s

Corporate Identity Number is U99999MH2000PTC126657, and its Compliance Officer [Vishal Bohra] contact details are:

Tel:+91-022-61759994, Fax:+91-022-61759851, Email: cgmcompliance@citi.com. The Investor Charter in respect of Research

Analysts, the Compliance Audit Report and Complaints information can be found at

https://www.citivelocity.com/cvr/eppublic/citi_research_disclosures. The grievance officer [Niraj Mody] contact details are

Tel: +91-22-42775002, Email: EMEA.CR.Complaints@citi.com. Investment in securities market are subject to market risks.